α-blockers

February 3, 2017February 3, 2017

BPH Patients Using 5-ARIs Not at Higher Risk of Dying of Prostate Cancer, Study Reports

News

Patients with benign prostatic hyperplasia (BPH) who are treated with enzyme 5-alpha reductase inhibitors (5-ARIs) are not at a higher risk of dying of prostate cancer than those using α-blockers, a new study reports. ... Read more

August 3, 2016

BPH Patients Respond Better to Combo Therapy of Detrol and Cardura, According to Study

News

Researchers assessed the efficacy and safety of a combination therapy of two different α-blockers, Cardura (doxazosin) and Flomax (tamsulosin), with Detrol (tolterodine), as evidence supports the superiority of this strategy over ... Read more